News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Cobra BioManufacturing (CBF.L) Successfully Passes Inspection by UK Regulators

9/1/2009 2:25:00 PM

Keele, UK: 1 September 2009, Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces that it has completed a successful audit by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) at its facility based at Keele.

This authorisation is the result of a recent 3 day inspection and evaluation by the agency of Cobra’s manufacturing, analytical and quality management systems and demonstrates that Cobra’s facilities continue to meet international Good Manufacturing Practice (cGMP) standards.

Simon Saxby, Chief Executive of Cobra Biomanufacturing commented:

“This is excellent news and ongoing confirmation of the commitment of the company to meet the needs of worldwide Regulatory agencies. The renewal of our Manufacturers and Importers Authorisation for Investigational Medicinal Products. MIA(IMP) licence acknowledges almost 10 years of cGMP compliance at Cobra and provision of a reliable and responsive biomanufacturing service to over 75 clients worldwide”.

About Cobra Biomanufacturing Plc:

Cobra Biomanufacturing Plc is a leading international manufacturer of biopharmaceuticals to the lifescience industry. Founded in 1992, Cobra provides innovative manufacturing solutions to the biopharmaceutical industry covering DNA, virus, cellular therapeutics and recombinant protein products.

Cobra has developed a range of unique, patented technologies, which underpin a successful revenue generating contract manufacturing business.

About the MHRA:

The MHRA was set up in April 2003 from a merger of the Medicines Control Agency and the Medical Devices Agency.

The MHRA is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe.

This email, its content and any files transmitted with it are confidential and are intended only for the addressee. If you are not the addressee, you may not print, copy, use or rely on the contents, attachments or information in any way except with the express written permission of the sender. If this email has been sent to you in error please destroy it and contact the sender. This email has been prepared using information believed by the author to be reliable and accurate, but College Hill makes no warranty as to its accuracy or completeness.

In particular, College Hill does not accept changes made to this email after it was sent.

Read at

comments powered by Disqus